Care Access
Media & News
From new hires and strategic partnerships to new clinical trial announcements and scientific research published in medical journals, hear all the latest ways we’re transforming the healthcare industry.
Direct-to-Patient Clinical Research: Care Access Shares Solutions at IoT Clinical Trials Conference
Taking research sites directly to local communities may hold the key to decreasing patient burden. An estimated 70 percent of potential trial participants live over two hours away from the nearest research center, forcing many to think twice about enrolling in a clinical study.¹ Traveling to dista...
Read MoreDecentralized and Direct-To-Patient Trials: Care Access CEO & Co-Founder Shares Insights at Future Trials Conference
Care Access CEO and Co-Founder Ahmad Namvargolian is on a mission to remove barriers to clinical trials for sponsors, physicians and patients, and to make research studies accessible for all. This mission was put to the test in the spring of 2020, when the COVID-19 pandemic sent the world screechin...
Care Access Research Collaborates with AstraZeneca on Phase III Clinical Trial for COVID-19 Long-Acting Antibody Combination
BOSTON, January 26, 2021 — (BUSINESS WIRE) — Care Access Research, a decentralized research organization (DRO) that operates as one connected team of physicians and research experts, today announced a collaboration with global biopharmaceutical company AstraZeneca to accelerate a clinical trial in...
Read MoreCare Access Research Partners on Revolutionary Mobile Clinical Trial for COVID-19 Treatment
BOSTON — (BUSINESS WIRE) — Care Access Research, the leader in rapid development and management of high-performing clinical research sites, announced that it is collaborating with global healthcare leader Eli Lilly and Company. Care Access Research is helping Lilly manage the first-of-its-kind sys...
Read MoreCare Access Research Validation Study of COVID-19 At-Home Saliva Test by Phosphorus is Granted EUA by FDA
BOSTON, July 2, 2020 (Newswire.com) — Care Access Research, the leader in rapid development and management of high-performing clinical research sites, announced that its validation study of a saliva-based COVID-19 at-home viral test for Phosphorus was granted Emergency Use Authorization by the FDA...
Read More